Nexalin Technology (NXL) Revenue (2021 - 2026)
Nexalin Technology (NXL) posted Revenue of $12161.0 for Q2 2026, down 18.66% on a QoQ basis from $14950.0 in Q1 2026, and down 82.77% year-over-year from $70588.0 in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Revenue (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Revenue for 6 years, with the latest figure at $12161.0 in Q2 2026.
- On a quarterly basis, Revenue fell 82.77% year-over-year to $12161.0 in Q2 2026; TTM through Jun 2026 was $217155.0, a 24.22% increase from a year earlier, with the FY2025 full-year figure at $301647.0, up 78.78% from the prior year.
- Revenue was $12161.0 for Q2 2026 at Nexalin Technology, down from $14950.0 in the prior quarter.
- The five-year high for Revenue was $545323.0 in Q3 2022, with the low at $12161.0 in Q2 2026.
- Average Revenue over 5 years is $107199.2, with a median of $35785.5 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Revenue soared 874.31% in 2022, then sank 95.58% in 2023.
- Over 5 years, Revenue stood at $38424.0 in 2022, then slumped by 46.55% to $20536.0 in 2023, then surged by 32.35% to $27179.0 in 2024, then surged by 532.46% to $171895.0 in 2025, then tumbled by 92.93% to $12161.0 in 2026.
- The last three Revenue figures came in at $12161.0 (Q2 2026), $14950.0 (Q1 2026), and $171895.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn | 2.89 Bn |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn | 9.76 Bn |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn | 6.59 Bn |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn | 5.44 Bn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn | 1.74 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | 2.78 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 1.31 Bn |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn | 1.49 Bn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 12,161.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,161.00 |
| Mar 31, 2026 | 14,950.00 |
| Dec 31, 2025 | 171,895.00 |
| Sep 30, 2025 | 18,149.00 |
| Jun 30, 2025 | 70,588.00 |
| Mar 31, 2025 | 41,015.00 |
| Dec 31, 2024 | 27,179.00 |
| Sep 30, 2024 | 36,031.00 |
| Jun 30, 2024 | 26,840.00 |
| Mar 31, 2024 | 78,671.00 |
| Dec 31, 2023 | 20,536.00 |
| Sep 30, 2023 | 24,113.00 |
| Jun 30, 2023 | 35,540.00 |
| Mar 31, 2023 | 30,560.00 |
| Dec 31, 2022 | 38,424.00 |
| Sep 30, 2022 | 545,323.00 |
| Jun 30, 2022 | 414,288.00 |
| Mar 31, 2022 | 323,322.00 |
| Dec 31, 2021 | 23,999.00 |
| Sep 30, 2021 | 55,970.00 |